Literature DB >> 9469163

Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat.

O Peters1, T Back, U Lindauer, C Busch, D Megow, J Dreier, U Dirnagl.   

Abstract

In barbiturate-anesthetized rats, we induced 3 hours of permanent middle cerebral artery occlusion (MCAO) by an intraluminal thread (n = 6), or 1 hour MCAO followed by 2 hours of reperfusion (n = 6). Through a closed cranial window over the parietal cortex, the production of reactive oxygen species (ROS) was measured in the infarct border using online in vivo chemiluminescence (CL) while monitoring the appearance of peri-infarct depolarizations (PID). The borderzone localization of the ROS and direct current (DC) potential measurements was confirmed in additional experiments using laser-Doppler scanning, mapping regional CBF changes through the cranial window after permanent (n = 5) or reversible (n = 5) MCAO. CL measurements revealed a short period (10 to 30 minutes) of reduced ROS formation after vessel occlusion, followed by a significant increase (to 162 +/- 51%; baseline = 100%; P < .05) from 100 minutes of permanent MCAO onward. Reperfusion after a 1-hour period of MCAO led to a burst-like pattern of ROS production (peak: 489 +/- 330%; P < .05). When the experiments were terminated 3 hours after induction of MCAO, CL was still significantly increased above baseline after permanent and reversible MCAO (to 190 +/- 67% and 211 +/- 64%, respectively; P < .05). Simultaneous DC potential recordings detected 6.4 +/- 2.7 PID in the first, 4.7 +/- 2.3 in the second, and 2.8 +/- 2.0 in the third hour after permanent MCAO. In animals with reversible MCAO, PID were abolished from 15-minutes recirculation onward. There was no temporal relationship between ROS production and peri-infarct DC potential shifts. In conclusion, using a high temporal resolution ROS detection technique (CL), we found that permanent MCAO (after an initial decrease) was accompanied by a steady increase of ROS production during the 3-hour observation period, while reperfusion after 1 hour of MCAO produced a burst in ROS formation. Both patterns of ROS production were not related to the occurrence of PID.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9469163     DOI: 10.1097/00004647-199802000-00011

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  79 in total

Review 1.  Estrogen neuroprotection and the critical period hypothesis.

Authors:  Erin Scott; Quan-guang Zhang; Ruimin Wang; Ratna Vadlamudi; Darrell Brann
Journal:  Front Neuroendocrinol       Date:  2011-11-04       Impact factor: 8.606

2.  Gene therapy using SOD1 protects striatal neurons from experimental stroke.

Authors:  Alexis S Davis; Heng Zhao; Guo Hua Sun; Robert M Sapolsky; Gary K Steinberg
Journal:  Neurosci Lett       Date:  2006-11-15       Impact factor: 3.046

3.  Salidroside Reduces Inflammation and Brain Injury After Permanent Middle Cerebral Artery Occlusion in Rats by Regulating PI3K/PKB/Nrf2/NFκB Signaling Rather than Complement C3 Activity.

Authors:  X Zhang; W Lai; X Ying; L Xu; K Chu; J Brown; L Chen; G Hong
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

4.  Reducing effect of IL-32α in the development of stroke through blocking of NF-κB, but enhancement of STAT3 pathways.

Authors:  Chul Ju Hwang; Hyung-Mun Yun; Yu Yeon Jung; Dong Hun Lee; Na Young Yoon; Hyun Ok Seo; Jin-Yi Han; Ki-Wan Oh; Dong Young Choi; Sang-Bae Han; Do Young Yoon; Jin Tae Hong
Journal:  Mol Neurobiol       Date:  2014-05-24       Impact factor: 5.590

Review 5.  Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment.

Authors:  Shadi Yaghi; Andrew Eisenberger; Joshua Z Willey
Journal:  JAMA Neurol       Date:  2014-09       Impact factor: 18.302

Review 6.  Nrf2-a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke.

Authors:  Rongrong Zhang; Mengxue Xu; Yu Wang; Fei Xie; Gang Zhang; Xinyue Qin
Journal:  Mol Neurobiol       Date:  2016-09-30       Impact factor: 5.590

7.  Safranal protects against ischemia-induced PC12 cell injury through inhibiting oxidative stress and apoptosis.

Authors:  Fatemeh Forouzanfar; Elham Asadpour; Hossein Hosseinzadeh; Mohammad Taher Boroushaki; Afrouz Adab; Seyedeh Hoda Dastpeiman; Hamid R Sadeghnia
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-31       Impact factor: 3.000

Review 8.  Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury.

Authors:  Xing-miao Chen; Han-sen Chen; Ming-jing Xu; Jian-gang Shen
Journal:  Acta Pharmacol Sin       Date:  2012-07-30       Impact factor: 6.150

9.  Effect of anesthesia and cerebral blood flow on neuronal injury in a rat middle cerebral artery occlusion (MCAO) model.

Authors:  C Bleilevens; A B Roehl; A Goetzenich; N Zoremba; M Kipp; J Dang; R Tolba; R Rossaint; M Hein
Journal:  Exp Brain Res       Date:  2012-10-13       Impact factor: 1.972

10.  Neuroprotective effects of ethyl pyruvate on brain energy metabolism after ischemia-reperfusion injury: a 31P-nuclear magnetic resonance study.

Authors:  Osamu Tokumaru; Chihiro Kuroki; Noriko Yoshimura; Tetsuro Sakamoto; Hidehiro Takei; Kazue Ogata; Takaaki Kitano; Naoko Nisimaru; Isao Yokoi
Journal:  Neurochem Res       Date:  2008-11-05       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.